PubMed:8554451
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 469-486 | protein | denotes | estrogen receptor |
| T2 | 491-512 | protein | denotes | progesterone receptor |
| T3 | 531-534 | protein | denotes | p53 |
| T4 | 539-548 | protein | denotes | HER-2/neu |
| T5 | 665-674 | protein | denotes | HER-2/neu |
| T6 | 715-731 | protein | denotes | type IV collagen |
| T7 | 736-743 | protein | denotes | laminin |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-41 | Sentence | denotes | Immunophenotype of intraductal carcinoma. |
| S2 | 42-248 | Sentence | denotes | OBJECTIVE: Mammography and breast-conserving therapy have focused attention on the classification of intraductal carcinoma (IDC) and emphasized the prognostic importance of comedo versus noncomedo variants. |
| S3 | 249-396 | Sentence | denotes | We used histochemical markers to define the immunophenotype of 43 IDCs with respect to comedo versus noncomedo status and patterns of angiogenesis. |
| S4 | 397-587 | Sentence | denotes | RESULTS: Reactions in comedo carcinomas were significantly negative for estrogen receptor and progesterone receptor, and positive for p53 and HER-2/neu more often than the noncomedo variant. |
| S5 | 588-675 | Sentence | denotes | All seven IDCs associated with Paget's disease showed positive reactions for HER-2/neu. |
| S6 | 676-887 | Sentence | denotes | Basement membrane immunoreactivity for type IV collagen and laminin was discontinuous in most examples of IDC regardless of type, with a trend toward more intense staining in comedo than in noncomedo carcinomas. |
| S7 | 888-1008 | Sentence | denotes | Periductal angiogenesis was not significantly related to the type of IDC but was more pronounced with comedo carcinomas. |
| S8 | 1009-1141 | Sentence | denotes | CONCLUSIONS: These observations indicate that there are immunophenotypic correlates to the current structural classification of IDC. |
| S9 | 1142-1321 | Sentence | denotes | The immunophenotype of IDC is helpful in subclassifying an IDC and could prove useful as a prognostic indicator for local control in patients treated by breast-conserving therapy. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 19-40 | NP | denotes | intraductal carcinoma |
| C1 | 0-40 | NP | denotes | Immunophenotype of intraductal carcinoma |
| C3 | 69-94 | NP | denotes | breast-conserving therapy |
| C4 | 143-170 | NP | denotes | intraductal carcinoma (IDC) |
| C5 | 419-436 | NP | denotes | comedo carcinomas |
| C6 | 782-785 | NP | denotes | IDC |
| C7 | 957-960 | NP | denotes | IDC |
| C8 | 990-1007 | NP | denotes | comedo carcinomas |
| C9 | 1137-1140 | NP | denotes | IDC |
| C11 | 1165-1168 | NP | denotes | IDC |
| C10 | 1142-1168 | NP | denotes | The immunophenotype of IDC |
| C12 | 1198-1204 | NP | denotes | an IDC |
| C13 | 1295-1320 | NP | denotes | breast-conserving therapy |
| R1 | C4 | C2 | coref-ident | intraductal carcinoma (IDC),intraductal carcinoma |
| R2 | C6 | C4 | coref-ident | IDC,intraductal carcinoma (IDC) |
| R3 | C7 | C6 | coref-ident | IDC,IDC |
| R4 | C8 | C5 | coref-ident | comedo carcinomas,comedo carcinomas |
| R5 | C9 | C7 | coref-ident | IDC,IDC |
| R6 | C11 | C9 | coref-ident | IDC,IDC |
| R7 | C10 | C1 | coref-ident | The immunophenotype of IDC,Immunophenotype of intraductal carcinoma |
| R8 | C12 | C11 | coref-ident | an IDC,IDC |
| R9 | C13 | C3 | coref-ident | breast-conserving therapy,breast-conserving therapy |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 19-40 | other_name | denotes | intraductal carcinoma |
| T2 | 53-64 | other_name | denotes | Mammography |
| T3 | 69-94 | other_name | denotes | breast-conserving therapy |
| T4 | 143-164 | other_name | denotes | intraductal carcinoma |
| T5 | 166-169 | other_name | denotes | IDC |
| T6 | 293-308 | other_name | denotes | immunophenotype |
| T7 | 315-319 | other_name | denotes | IDCs |
| T8 | 383-395 | other_name | denotes | angiogenesis |
| T9 | 419-436 | other_name | denotes | comedo carcinomas |
| T10 | 469-477 | lipid | denotes | estrogen |
| T11 | 491-503 | lipid | denotes | progesterone |
| T12 | 531-534 | protein_subunit | denotes | p53 |
| T13 | 539-548 | protein_molecule | denotes | HER-2/neu |
| T14 | 569-586 | other_name | denotes | noncomedo variant |
| T15 | 598-602 | other_name | denotes | IDCs |
| T16 | 665-674 | protein_molecule | denotes | HER-2/neu |
| T17 | 715-731 | protein_complex | denotes | type IV collagen |
| T18 | 736-743 | protein_complex | denotes | laminin |
| T19 | 782-785 | other_name | denotes | IDC |
| T20 | 851-857 | other_name | denotes | comedo |
| T21 | 866-886 | other_name | denotes | noncomedo carcinomas |
| T22 | 899-911 | other_name | denotes | angiogenesis |
| T23 | 957-960 | other_name | denotes | IDC |
| T24 | 990-1007 | other_name | denotes | comedo carcinomas |
| T25 | 1137-1140 | other_name | denotes | IDC |
| T26 | 1146-1161 | other_name | denotes | immunophenotype |
| T27 | 1165-1168 | other_name | denotes | IDC |
| T28 | 1201-1204 | other_name | denotes | IDC |
| T29 | 1295-1320 | other_name | denotes | breast-conserving therapy |